Caricamento...
Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer
Programmed death ligand 1 (PD-L1) immune checkpoint inhibitors are promising therapeutic agents for treating cancers but the response rate is <20%. Some chemotherapeutic drugs could also activate an anticancer immune response to kill cancer cells, apart from their direct cytotoxicity. Our study i...
Salvato in:
| Pubblicato in: | Signal Transduct Target Ther |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7452895/ https://ncbi.nlm.nih.gov/pubmed/32855386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-020-0200-4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|